ID: h-6c06ca11ee
Hypothesis
Vascular Cell Type Crosstalk Driving Blood-Brain Barrier Breakdown
Pericyte-endothelial cross-talk failure leads to MMP9-mediated BBB disruption and tau propagation.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
Pericyte-endothelial cross-talk failure leads to MMP9-mediated BBB disruption and tau propagation. Single-nucleus data reveals pericytes downregulate PDGFRB and CLDN5, while endothelial cells lose TJP1 (ZO-1) expression, correlating with elevated MMP9 in neutrophils and microglia.
🧬 Mechanism
🔗 Mechanism from KG for MMP9
Auto-built from this analysis's top knowledge-graph edges.
graph TD
MMP9["MMP9"] -->|causes| BBB_breakdown["BBB breakdown"]
MMP9_1["MMP9"] -->|causes| Tau_Propagation["Tau Propagation"]
MMP9_2["MMP9"] -->|mediates| Basement_membrane_degrada["Basement membrane degradation"]
MMP9_3["MMP9"] -->|causes| BBB_disruption["BBB disruption"]
style MMP9 fill:#ce93d8,stroke:#333,color:#000
style BBB_breakdown fill:#4fc3f7,stroke:#333,color:#000
style MMP9_1 fill:#ce93d8,stroke:#333,color:#000
style Tau_Propagation fill:#4fc3f7,stroke:#333,color:#000
style MMP9_2 fill:#4fc3f7,stroke:#333,color:#000
style Basement_membrane_degrada fill:#4fc3f7,stroke:#333,color:#000
style MMP9_3 fill:#4fc3f7,stroke:#333,color:#000
style BBB_disruption fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
⚖️ Evidence Matrix3 supports2 contradicts
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — MMP9
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for MMP9.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.9%
Volatility
Low
0.0022
Events (7d)
3
Price History
▼11.8%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF pericyte-specific PDGFRB is genetically restored via AAV-PDGFRB delivery to 10-month-old C57BL/6 mice with laser-induced BBB disruption THEN MMP9 activity in cortical neutrophils/microglia will dec | ≥50% reduction in MMP9 activity (gelatin zymography); ≥60% recovery of TJP1+ endothelial cells; ≥35% decrease in plasma tau | — no observation — | pending | 0.55 |
| IF selective MMP9 inhibitor (3 mg/kg, i.p., daily) is administered to aged APP/PS1 mice (12-month-old) for 8 weeks THEN serum tau species (tau 181, tau 217) will decrease by ≥40% and BBB integrity mar | ≥40% reduction in circulating p-tau181 and p-tau217; ≥30% improvement in BBB integrity metrics | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF selective MMP9 inhibitor (3 mg/kg, i.p., daily) is administered to aged APP/PS1 mice (12-month-old) for 8 weeks THEN serum tau species (tau 181, tau 217) will decrease by ≥40% and BBB integrity markers (CSF/serum albumin ratio) will normalize by ≥30% compared to vehicle-treated controls, as MMP9-
Predicted outcome: ≥40% reduction in circulating p-tau181 and p-tau217; ≥30% improvement in BBB integrity metrics
Falsification: No significant change in circulating tau levels or BBB permeability markers despite sustained MMP9 inhibition, indicating MMP9 is not the primary driver of tau propagation via BBB breakdown.
pendingconf 55%
IF pericyte-specific PDGFRB is genetically restored via AAV-PDGFRB delivery to 10-month-old C57BL/6 mice with laser-induced BBB disruption THEN MMP9 activity in cortical neutrophils/microglia will decline by ≥50%, endothelial TJP1 (ZO-1) expression will recover by ≥60%, and circulating tau will decr
Predicted outcome: ≥50% reduction in MMP9 activity (gelatin zymography); ≥60% recovery of TJP1+ endothelial cells; ≥35% decrease in plasma tau
Falsification: PDGFRB restoration fails to reduce MMP9 activity or restore endothelial junctions, indicating pericyte PDGFRB downregulation is not the upstream trigger for MMP9-mediated BBB breakdown.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.